{"id":"https://openalex.org/W341598154","doi":null,"title":"New therapeutic approaches in Alzheimer's disease.","display_name":"New therapeutic approaches in Alzheimer's disease.","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W341598154","mag":"341598154","pmid":"https://pubmed.ncbi.nlm.nih.gov/15679044"},"language":"en","primary_location":{"id":"pmid:15679044","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15679044","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia neuropathologica","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067111738","display_name":"Maria Barcikowska","orcid":"https://orcid.org/0000-0001-5657-9670","observed_orcids":["https://orcid.org/0000-0001-5657-9670"]},"institutions":[{"id":"https://openalex.org/I4210157213","display_name":"Mossakowski Medical Research Institute,  Polish Academy of Sciences","ror":"https://ror.org/05d3ntb42","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210157213","https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":true,"raw_author_name":"Maria Barcikowska","raw_affiliation_strings":["Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre, Warszawa. mariab@cmdik.pan.pl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre, Warszawa. mariab@cmdik.pan.pl","institution_ids":["https://openalex.org/I4210157213"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5067111738"],"corresponding_institution_ids":["https://openalex.org/I4210157213"],"apc_list":null,"apc_paid":null,"fwci":0.2173,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.41918354,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"42","issue":"4","first_page":"251","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":1.0},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.800000011920929},{"id":"https://openalex.org/keywords/secretase-inhibitors","display_name":"secretase inhibitors","score":0.9860000014305115},{"id":"https://openalex.org/keywords/cholesterol-lowering-drugs","display_name":"cholesterol-lowering drugs","score":0.8709999918937683},{"id":"https://openalex.org/keywords/metal-chelators","display_name":"metal chelators","score":0.9959999918937683},{"id":"https://openalex.org/keywords/anti-inflammatory-agents","display_name":"anti-inflammatory agents","score":0.9879999756813049},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/memantine","display_name":"memantine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.8240000009536743},{"id":"https://openalex.org/keywords/dementia-diagnosis","display_name":"dementia diagnosis","score":0.6100000143051147},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.8016167879104614},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6990607976913452},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.6164008378982544},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6082384586334229},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.4556879699230194},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.4372771382331848},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4175393581390381},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3980083465576172},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.35791265964508057},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33245307207107544},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.22264966368675232},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17868754267692566},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14582297205924988},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000071679","descriptor_name":"Glycogen Synthase Kinase 3 beta","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010450","descriptor_name":"Endopeptidases","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016282","descriptor_name":"Aspartic Acid Endopeptidases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016564","descriptor_name":"Amyloid beta-Protein Precursor","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016564","descriptor_name":"Amyloid beta-Protein Precursor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016875","descriptor_name":"tau Proteins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D038362","descriptor_name":"Glycogen Synthase Kinase 3","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D053829","descriptor_name":"Amyloid Precursor Protein Secretases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15679044","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15679044","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia neuropathologica","raw_type":"Journal Article"},{"id":"mag:341598154","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15679044","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1675105744","https://openalex.org/W1693283493","https://openalex.org/W1975806945","https://openalex.org/W2000917982","https://openalex.org/W2003283600","https://openalex.org/W2009111659","https://openalex.org/W2030079540","https://openalex.org/W2040721710","https://openalex.org/W2050181337","https://openalex.org/W2051516838","https://openalex.org/W2085754422","https://openalex.org/W2092356280","https://openalex.org/W2119141718","https://openalex.org/W2121448546","https://openalex.org/W2137777161","https://openalex.org/W2168866787"],"related_works":["https://openalex.org/W2155039139","https://openalex.org/W2341061248","https://openalex.org/W2033863809","https://openalex.org/W2317583919","https://openalex.org/W1017832383","https://openalex.org/W2019261301","https://openalex.org/W2186563374","https://openalex.org/W2393423250","https://openalex.org/W2118420513","https://openalex.org/W1993756815"],"abstract_inverted_index":{"Alzheimer's":[0],"disease":[1,56,61],"(AD)":[2],"is":[3,29,139,159],"a":[4,10,19,160],"progressive":[5,20],"neurodegenerative":[6],"disorder":[7],"that":[8,64,156],"affects":[9],"large":[11],"proportion":[12],"of":[13,33,54,71,94,104,110,120,148,174],"the":[14,36,52,55,108,124,131,178],"elderly":[15],"population.":[16],"It":[17],"causes":[18],"decline":[21],"in":[22,39,99,176],"memory":[23],"and":[24,82,101,137,167],"other":[25],"cognitive":[26],"functions.":[27],"There":[28,158],"no":[30],"effective":[31],"treatment":[32,70],"AD":[34,72,105,175],"despite":[35],"great":[37,161],"effort":[38],"trying":[40],"to":[41,87,142,152],"find":[42,143],"one.":[43],"Herein":[44],"new":[45],"therapeutic":[46],"approaches":[47],"including":[48],"those":[49],"closely":[50],"targeting":[51],"pathogenesis":[53],"have":[57],"been":[58],"discussed.":[59],"Potential":[60],"modifying":[62],"treatments":[63],"are":[65,97,127],"being":[66],"considered":[67],"as":[68],"future":[69],"include":[73],"avaccination,":[74],"secretase":[75],"inhibitors,":[76],"cholesterol":[77],"lowering":[78],"drugs,":[79],"metal":[80],"chelators":[81],"anti-":[83],"inflammatory":[84],"agents.":[85],"According":[86],"Evidence":[88],"Based":[89],"Dementia":[90],"Practice,":[91],"only":[92,141],"inhibitors":[93],"acetylcholinesterase":[95],"(AChE)":[96],"approved":[98,114],"mild":[100],"moderate":[102],"stages":[103],"treatment.":[106],"From":[107],"end":[109],"2003,":[111],"FDA":[112],"also":[113,151],"memantine":[115],"for":[116,135,145,155,163,172],"much":[117],"severer":[118],"phases":[119],"AD.":[121],"When":[122],"all":[123],"presented":[125],"possibilities":[126],"taken":[128],"into":[129],"account,":[130],"most":[132],"important":[133],"target":[134],"scientists":[136],"physicians":[138],"not":[140,183],"ways":[144],"causative":[146],"cure":[147],"AD,":[149],"but":[150],"be":[153],"ready":[154],"moment.":[157],"need":[162],"finding":[164],"routine":[165],"biomarkers":[166],"sensitive":[168],"enough":[169],"clinical":[170],"tests":[171],"diagnosis":[173],"which":[177],"lasting":[179],"pathological":[180],"process":[181],"does":[182],"destroy":[184],"too":[185],"many":[186],"neurones.":[187]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}